 |
 |
 |
|
HBV rtN236T Mutant Subpopulations Respond Like Wild-Type During Tenofovir DF (TDF) Monotherapy or Combination Therapy with Emtricitabine (FTC)
|
|
|
Reported by Jules Levin
21st Conference of the Asian Pacific Association for the Study of the Liver (APASL)
February 17-20, 2011
Bangkok, Thailand
M Curtis1, E Svarovskaia2, Y Zhu1, K Peschell1, K Kitrinos2, M Miller2, and K Borroto-Esoda1
1Gilead Sciences, Inc., Durham, NC, USA; 2Gilead Sciences, Inc., Foster City, CA, USA






|
|
|
 |
 |
|
|